Suppr超能文献

通过特异性DNA扩增检测隐匿性滤泡性淋巴瘤

Detection of occult follicular lymphoma by specific DNA amplification.

作者信息

Stetlet-Stevenson M, Raffeld M, Cohen P, Cossman J

机构信息

Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892.

出版信息

Blood. 1988 Nov;72(5):1822-5.

PMID:3140914
Abstract

To detect occult lymphoma, the polymerase chain reaction (PCR) technique was used to amplify joined bcl-2/JH DNA sequences at the juncture of the t(14:18) translocation in follicular lymphoma. Using the heat-stable DNA polymerase Taq and automated cycling of the reaction, we were able to detect as few as one to two copies of bcl-2/JH. Under these conditions, PCR proved to be at least 10,000-fold more sensitive than either conventional flow cytometry or Southern blot restriction analysis. In addition, genomic DNA sequences of four lymphomas confirmed that the size of the amplified segment serves as a tumor marker. Direct application of PCR to patient staging revealed occult malignant lymphoma in tissue otherwise considered uninvolved by standard criteria. We conclude that the striking enhancement in diagnostic sensitivity attained by DNA amplification can serve as a valuable adjunct to the staging and clinical monitoring of follicular lymphoma.

摘要

为检测隐匿性淋巴瘤,采用聚合酶链反应(PCR)技术扩增滤泡性淋巴瘤中t(14:18)易位连接处的连接bcl-2/JH DNA序列。使用热稳定DNA聚合酶Taq并对反应进行自动循环,我们能够检测到低至一到两个bcl-2/JH拷贝。在这些条件下,PCR被证明比传统流式细胞术或Southern印迹限制性分析至少敏感10000倍。此外,四个淋巴瘤的基因组DNA序列证实扩增片段的大小可作为肿瘤标志物。将PCR直接应用于患者分期,发现在标准标准认为未受累的组织中存在隐匿性恶性淋巴瘤。我们得出结论,DNA扩增所实现的诊断敏感性的显著提高可作为滤泡性淋巴瘤分期和临床监测的有价值辅助手段。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验